v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Previously Reported
Common Stock
Additional paid in capital
Accumulated other comprehensive income
Retained earnings
Retained earnings
Cumulative Effect, Period of Adoption, Adjustment
Retained earnings
Previously Reported
Balance at beginning of period (in shares) at Dec. 31, 2024       19,106          
Balance at beginning of period at Dec. 31, 2024 $ 830,439 $ (438)   $ 20 $ 337,377 $ (5,942) $ 498,984 $ (438)  
Increase (Decrease) in Stockholders' Equity                  
Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes (in shares)       170          
Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes (4,669)       (4,669)        
Share-based compensation 7,836       7,836        
Unrealized (loss) gain on available-for-sale securities, net of tax (22)         (22)      
Foreign currency translation adjustment, net of tax 4,401         4,401      
Net income (loss)   498 $ (42,451)         498 $ (42,451)
Balance at end of period (in shares) at Mar. 31, 2025 [1]       19,276          
Balance at end of period at Mar. 31, 2025 [1] 795,594     $ 20 340,544 (1,563) 456,593    
Balance at beginning of period (in shares) at Dec. 31, 2024       19,106          
Balance at beginning of period at Dec. 31, 2024 830,439 (438)   $ 20 337,377 (5,942) 498,984 (438)  
Increase (Decrease) in Stockholders' Equity                  
Unrealized (loss) gain on available-for-sale securities, net of tax 7                
Foreign currency translation adjustment, net of tax 15,257                
Net income (loss) 79,669                
Balance at end of period (in shares) at Sep. 30, 2025       19,656          
Balance at end of period at Sep. 30, 2025 950,171     $ 20 362,614 9,322 578,215    
Balance at beginning of period (in shares) at Mar. 31, 2025 [1]       19,276          
Balance at beginning of period at Mar. 31, 2025 [1] 795,594     $ 20 340,544 (1,563) 456,593    
Increase (Decrease) in Stockholders' Equity                  
Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes (in shares)       135          
Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes 8,094       8,094        
Share-based compensation 9,997       9,997        
Unrealized (loss) gain on available-for-sale securities, net of tax (49)         (49)      
Foreign currency translation adjustment, net of tax 10,106         10,106      
Net income (loss)   (1,276) 4,847         (1,276) 4,847
Balance at end of period (in shares) at Jun. 30, 2025 [1]       19,411          
Balance at end of period at Jun. 30, 2025 [1] 827,313     $ 20 358,635 8,494 460,164    
Increase (Decrease) in Stockholders' Equity                  
Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes (in shares)       347          
Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes 25,523       25,523        
Share repurchase in connection with the Notes (Note 9) (in shares)       (102)          
Share repurchase in connection to the 2030 Notes (15,000)       (15,000)        
2030 Convertible Notes hedge and warrant transactions, net of tax (Note 7) (21,290)       (21,290)        
Share-based compensation 14,746       14,746        
Unrealized (loss) gain on available-for-sale securities, net of tax 78         78      
Foreign currency translation adjustment, net of tax 750         750      
Net income (loss) 117,273 $ 778 $ 117,273         $ 778 $ 117,273
Balance at end of period (in shares) at Sep. 30, 2025       19,656          
Balance at end of period at Sep. 30, 2025 $ 950,171     $ 20 362,614 9,322 578,215    
Balance at beginning of period (in shares) at Dec. 31, 2025 19,774     19,774          
Balance at beginning of period at Dec. 31, 2025 $ 1,017,212     $ 20 400,649 8,455 608,088    
Increase (Decrease) in Stockholders' Equity                  
Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes (in shares)       255          
Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes (14,076)       (14,076)        
Share-based compensation 10,596       10,596        
Unrealized (loss) gain on available-for-sale securities, net of tax (732)         (732)      
Foreign currency translation adjustment, net of tax (2,333)         (2,333)      
Net income (loss) (13,345)           (13,345)    
Balance at end of period (in shares) at Mar. 31, 2026       20,029          
Balance at end of period at Mar. 31, 2026 $ 997,322     $ 20 397,169 5,390 594,743    
Balance at beginning of period (in shares) at Dec. 31, 2025 19,774     19,774          
Balance at beginning of period at Dec. 31, 2025 $ 1,017,212     $ 20 400,649 8,455 608,088    
Increase (Decrease) in Stockholders' Equity                  
Unrealized (loss) gain on available-for-sale securities, net of tax (1,575)                
Foreign currency translation adjustment, net of tax (3,441)                
Net income (loss) $ 6,678                
Balance at end of period (in shares) at Sep. 30, 2026 20,001     20,001          
Balance at end of period at Sep. 30, 2026 $ 961,763     $ 20 403,538 3,439 554,766    
Balance at beginning of period (in shares) at Mar. 31, 2026       20,029          
Balance at beginning of period at Mar. 31, 2026 997,322     $ 20 397,169 5,390 594,743    
Increase (Decrease) in Stockholders' Equity                  
Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes (in shares)       120          
Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes 8,256       8,256        
Share repurchase in connection with the Notes (Note 9) (in shares)       (229)          
Share repurchase in connection with the Notes (Note 9) (60,000)           (60,000)    
2031 Notes hedge and warrant transactions, net of tax (39,309)       (39,309)        
Share-based compensation 13,653       13,653        
Unrealized (loss) gain on available-for-sale securities, net of tax (22)         (22)      
Foreign currency translation adjustment, net of tax (892)         (892)      
Net income (loss) 48,508           48,508    
Balance at end of period (in shares) at Jun. 30, 2026       19,920          
Balance at end of period at Jun. 30, 2026 967,516     $ 20 379,769 4,476 583,251    
Increase (Decrease) in Stockholders' Equity                  
Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes (in shares)       81          
Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes 5,588       5,588        
Share-based compensation 18,181       18,181        
Unrealized (loss) gain on available-for-sale securities, net of tax (821)         (821)      
Foreign currency translation adjustment, net of tax (216)         (216)      
Net income (loss) $ (28,485)           (28,485)    
Balance at end of period (in shares) at Sep. 30, 2026 20,001     20,001          
Balance at end of period at Sep. 30, 2026 $ 961,763     $ 20 $ 403,538 $ 3,439 $ 554,766    
[1]
*Interim equity balances reflect the impact of ASU 2025-07 adoption in Q3 2025 effective January 1, 2025.